去纤苷有哪几个版本?分别多少钱?

Defitelio is a drug used to treat hepatic veno-occlusive disease after hematopoietic stem cell transplantation. Its version information and price are of important reference value for patient treatment choices. This article will provide a detailed introduction to the pharmaceutical versions of defibrotide, price information, and accessibility in the Chinese market.

What are the versions of defibrotide?

As a special-purpose orphan drug, its production and sales have a specific market pattern. Understanding its version information can help patients correctly understand the drug.

Original drug version

Currently, there is only the original version of the drug produced by Jazz Pharmaceuticals in Ireland, with the trade name Defitelio. There is no generic version of this drug on the market yet, and it is produced by original manufacturers worldwide.

Specification information

The standard specification of Defitelio is 200mg/2.5mL injection. The pharmaceutical packaging usually contains several preparations of this specification. The specific quantity varies according to the market requirements of each country.

Global uniformity

Because it is an orphan drug and has special indications, the pharmaceutical ingredients, specifications and production standards of defibrotide are highly consistent worldwide, and there is no quality difference between products sold in different countries.

Patients should look for the Defitelio trademark and the production information of Jazz Pharmaceuticals when obtaining the drug, and avoid purchasing products from unknown sources.

How much do the different versions of defibrotide cost?

As a drug for rare diseases, the price of defibrotide is relatively high. Understanding its price information can help patients make a budget for treatment.

International market price

Currently, it is understood that the price of Defitelio in the U.S. market is approximately US$5,310 per box, and each box is 200mg/2.5mL. The specific price may fluctuate slightly depending on the region and purchasing channel.

Treatment Cost Estimation

According to standard treatment plans, a complete course of treatment may require multiple boxes of drugs, and the total treatment cost may reach tens of thousands of dollars. The actual dosage needs to be determined by the doctor based on the patient's weight and condition.

Factors affecting price

The research and development costs of defibrotide are high and there are few suitable patients. These factors together determine its higher market price. Some countries may have special subsidies or assistance projects.

Patients should confirm the latest price information through formal channels before purchasing and learn about possible cost assistance programs.

The listing and medical insurance status of defibrotide in China

The accessibility of defibrotide in the Chinese market directly affects the treatment options of domestic patients, and it is very necessary to understand its approval and reimbursement status.

Domestic Approval Status

As of now, defibrotide has not yet received marketing approval from the China National Medical Products Administration, and domestic patients are temporarily unable to purchase the drug through formal channels.

Medical insurance coverage

Since it is not marketed in China, defibrotide is naturally not included in any medical insurance reimbursement catalog. If patients need to use it, they need to pay for it in full and obtain it through special channels.

Discussion of alternative options

When defibrotide is unavailable, doctors may recommend other supportive treatment options based on the patient’s condition, and the specific choice needs to be evaluated and determined by a professional medical team.

If domestic patients need medication, it is recommended to consult the attending physician and the hospital pharmacy department to learn about the latest drug introduction trends and special medication application procedures.